Yaz Plus Tablet recall in Canada: dosage uniformity issue
In plain language
This recall involves Yaz Plus Tablets sold in Canada. It's being recalled because the dosage uniformity test is out of specification for affected lots. Stop using the product and follow the return steps in the official notice.
What to do
- Stop using the product immediately.
- Check the lot number if provided.
- Contact Bayer Inc. for instructions on return or disposal.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Yaz Plus Tablet
Lot: 71010A
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: 71010A
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
This recall involves Yaz Plus Tablets sold in Canada. It's being recalled because the dosage uniformity test is out of specification for affected lots. Stop using the product and follow the return steps in the official notice.
What should consumers do?
Stop using the product immediately. Check the lot number if provided. Contact Bayer Inc. for instructions on return or disposal.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on July 12, 2018.
Is the Yaz Plus brand affected by this recall?
Yes, Yaz Plus products are affected by this recall. This recall involves Yaz Plus Tablets sold in Canada. It's being recalled because the dosage uniformity test is out of specification for affected lots. Stop using the product and follow the return steps in the official notice.